Table 5 Univariate, bivariate results of female gender and started CD4 + T-Cell base value modeling and multivariate modeling and CD4 + T-Cell Base value simultaneously with other possible important covariates associated with CD4 + decline toward to HIV progression during study period.
Analysis | Models | Variable | Statistical Analysis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
n | Events % (n) | Censored % (n) | β(Beta) | SE(β) | [β/SE(β)]2 | Sig. (P-Value) | HR (eβ) | 95% CI for eβ | |||
Univariate | Model-1 | Gender: | 178 | 67 (119) | 33 (59) | ||||||
1. Males | 118 | 0 | 1 | Referent | 0 | 1 | Referent | ||||
2. Females | 60 | 0.343 | 0.194 | 3.114 | 0.0700 | 1.4 | 0.96, 2.06 | ||||
Model-2 | CD4 + T-Cell Base Value (in Hundreds) | 178 | 67 (119) | 33 (59) | − 0.255 | 0.066 | 14.674 | 0.0001 | 0.9 | 0.68, 0.88 | |
Bivariate | Model-1 | Gender: | 178 | 67 (119) | 33 (59) | ||||||
1. Males | 118 | 0 | 1 | Referent | 0 | 1 | Referent | ||||
2. Females | 60 | 0.352 | 0.194 | 3.279 | 0.0701 | 1.4 | 0.97, 2.08 | ||||
CD4 + T-cell base value (in hundreds) | 178 | 67 (119) | 33 (59) | − 0.251 | 0.066 | 14.319 | 0.0002 | 0.8 | 0.68,0.88 | ||
Multivariate | Model-1 | Gender: | 178 | 69 (119) | 33 (59) | ||||||
1. Males | 118 | 0 | 1 | Referent | 0 | 1 | Referent | ||||
2. Females | 60 | 0.657 | 0.223 | 8.628 | 0.0033 | 1.93 | 1.24, 2.99 | ||||
CD4 + T-Cell Base Value (in Hundreds) | 178 | 67 (119) | 33 (59) | − 0.387 | 0.093 | 17.313 | 0.0001 | 0.7 | 0.56, 0.81 | ||
Gender & CD4 + T-Cell base value (in Hundreds) and other covariates* in study | 178 | 67 (119) | 33 (59) | 0.281 | 0.117 | 5.779 | 0.0162 | 1.3 | 1.05, 1.66 | ||
